185 related articles for article (PubMed ID: 36139421)
1. A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease.
Elfiky AMI; Hageman IL; Becker MAJ; Verhoeff J; Li Yim AYF; Joustra VW; Mulders L; Fung I; Rioja I; Prinjha RK; Smithers NN; Furze RC; Mander PK; Bell MJ; Buskens CJ; D'Haens GR; Wildenberg ME; de Jonge WJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139421
[TBL] [Abstract][Full Text] [Related]
2. Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.
Elfiky AMI; Ghiboub M; Li Yim AYF; Hageman IL; Verhoeff J; de Krijger M; van Hamersveld PHP; Welting O; Admiraal I; Rahman S; Garcia-Vallejo JJ; Wildenberg ME; Tomlinson L; Gregory R; Rioja I; Prinjha RK; Furze RC; Lewis HD; Mander PK; Heinsbroek SEM; Bell MJ; de Jonge WJ
J Crohns Colitis; 2022 May; 16(4):668-681. PubMed ID: 34633041
[TBL] [Abstract][Full Text] [Related]
3. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
4. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
[TBL] [Abstract][Full Text] [Related]
5. Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.
Loganes C; Pin A; Naviglio S; Girardelli M; Bianco AM; Martelossi S; Tommasini A; Piscianz E
World J Gastroenterol; 2016 Nov; 22(41):9117-9126. PubMed ID: 27895399
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.
Liu C; Dunkin D; Lai J; Song Y; Ceballos C; Benkov K; Li XM
Inflamm Bowel Dis; 2015 Aug; 21(8):1918-25. PubMed ID: 25993687
[TBL] [Abstract][Full Text] [Related]
7. A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.
Nayar S; Morrison JK; Giri M; Gettler K; Chuang LS; Walker LA; Ko HM; Kenigsberg E; Kugathasan S; Merad M; Chu J; Cho JH
Nature; 2021 May; 593(7858):275-281. PubMed ID: 33789339
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia.
Furze RC; Molnar J; Parr NJ; Ahmad F; Henry Y; Howe D; Singh R; Toal M; Bassil AK; Bernard SG; Davis RP; Gibson A; Maller NC; Sharp C; Tough DF; Prinjha RK; Lewis HD
Br J Clin Pharmacol; 2022 Dec; 88(12):5238-5256. PubMed ID: 35655123
[TBL] [Abstract][Full Text] [Related]
9. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
Ngoh EN; Weisser SB; Lo Y; Kozicky LK; Jen R; Brugger HK; Menzies SC; McLarren KW; Nackiewicz D; van Rooijen N; Jacobson K; Ehses JA; Turvey SE; Sly LM
Gastroenterology; 2016 Feb; 150(2):465-76. PubMed ID: 26481854
[TBL] [Abstract][Full Text] [Related]
10. Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy.
Leal RF; Planell N; Kajekar R; Lozano JJ; Ordás I; Dotti I; Esteller M; Masamunt MC; Parmar H; Ricart E; Panés J; Salas A
Gut; 2015 Feb; 64(2):233-42. PubMed ID: 24700437
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.
Guidi L; Costanzo M; Ciarniello M; De Vitis I; Pioli C; Gatta L; Pace L; Tricerri A; Bartoloni C; Coppola L; Balistreri P; Doria G; Fedeli G; Gasbarrini GB
Int J Immunopathol Pharmacol; 2005; 18(1):155-64. PubMed ID: 15698520
[TBL] [Abstract][Full Text] [Related]
12. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
13. The expression IL1B correlates negatively with the clinical response to adalimumab in Crohn's disease patients: An ex vivo approach using peripheral blood mononuclear cells.
Gole B; Pernat C; Jezernik G; Potočnik U
Life Sci; 2023 Aug; 326():121822. PubMed ID: 37257580
[TBL] [Abstract][Full Text] [Related]
14. Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151, and IBET-762 in OSCC cells.
Baldan F; Allegri L; Lazarevic M; Catia M; Milosevic M; Damante G; Milasin J
J Oral Pathol Med; 2019 Mar; 48(3):214-221. PubMed ID: 30618144
[TBL] [Abstract][Full Text] [Related]
15. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
[TBL] [Abstract][Full Text] [Related]
16. Intestinal CD14+ Macrophages Protect CD4+ T Cells From Activation-induced Cell Death via Exosomal Membrane TNF in Crohn's Disease.
Liu H; Liang Z; Wang F; Zheng X; Zeng Z; He X; Gao X; Zhi M; Wu X; Wu X; Lan P
J Crohns Colitis; 2020 Nov; 14(11):1619-1631. PubMed ID: 32343772
[TBL] [Abstract][Full Text] [Related]
17. Crohn's Disease Patients with Depression Exhibit Alterations in Monocyte/Macrophage Phenotype and Increased Proinflammatory Cytokine Production.
Tang Y; Zhao L; Lei N; Chen P; Zhang Y
Dig Dis; 2020; 38(3):211-221. PubMed ID: 31216541
[TBL] [Abstract][Full Text] [Related]
18. Glycolytic Activation of CD14+ Intestinal Macrophages Contributes to the Inflammatory Responses via Exosomal Membrane Tumor Necrosis Factor in Crohn's Disease.
Zeng Z; Cheng S; Li X; Liu H; Lin J; Liang Z; Liu X; Cao C; Li S; He X; Kang L; Wu X; Zheng X
Inflamm Bowel Dis; 2024 Jan; 30(1):90-102. PubMed ID: 37406645
[TBL] [Abstract][Full Text] [Related]
19. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in the peripheral blood system of Crohn's Disease.
Li D; Gu W; Xu H; Zhang Z; Zhao C; He C; Zhu X; Li Y
Clin Exp Med; 2023 Oct; 23(6):2805-2812. PubMed ID: 36842094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
